We use cookies for a better user experience. Read our Privacy Policy

I Agree

Micro-RNA Market

MicroRNA Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2031

MicroRNA Market – Overview

The global microRNA market is projected to witness notable growth during the forecast period set between 2021 and 2031. This is attributed to the increasing number of diseases that requires microRNA applications as a means for clinical study or therapeutic purpose. The key market factors forming the future incorporate arising microRNA apparatuses for fluctuated disease-related applications, the utilization of microRNA in forecast and distinguishing proof, and the likely candidate for biopharma organizations to foster future medicines. Biopharma firms across the globe, are occupied with growing new molecules as a potential drug candidate likewise driving the microRNA market development.

The growing adoption of microRNA as a biomarker is a key factor driving the market. The miRNA biomarkers are of specific concentration in genome-wide investigations, information-driven methodology, as they show high reproducibility and power when contrasted with conventional strategies. Thus, they fill in as promising candidates for the improvement of biomarkers. Also, the developing interest in liquid biopsies has additionally prompted the expanding significance of miRNAs for biomarker disclosure and improvement.

The report on the global microRNA market provides a comprehensive overview of the market and how can it derive benefits in the coming years. Additionally, the impact of the novel COVID19 pandemic prevalent on this market and the key strategies that can be adopted by players to gain benefit from this situation are also discussed in details in this report. Factors attributing to the growth or downfall of this market such as drivers, restraints, challenges, and upcoming growth opportunities are also listed in this report. Additionally, the report also provides the list of all players and their chief contributions to the market.

Expanding operations in future? To get the perfect launch ask for a custom report

MicroRNA Market – Competitive Landscape

Biopharmaceutical companies are progressively captivating in the quest for new remedial molecules that can go about as new drugs that are further driving the market for microRNA. There are a few miRNA-based candidates that are under clinical preliminaries, for example, hostile to miR mixtures and explicit inhibitors for miRNAs which can go about as likely remedial solutions. Henceforth, RNA therapeutics is viewed as a moving contributing region that will prompt the advancement of productive drugs.

Some of the key players of the global microRNA market include:

  • Biodynamics Laboratory Inc.
  • Miltenyi Biotec
  • BioGenex
  • Quantabio
  • GeneCopoeia Inc.
  • Synlogic
  • Thermo Fisher Scientific Inc.
  • OriGene Technologies Inc.
  • Sistemic Scotland Limited
  • SwqMatic LLC
  • NanoString
  • New England Biolabs
  • Horizon Discovery Ltd.
  • Merck KGaA
  • Other players

MicroRNA Market – List of Innovations

  •  Scinogy and Thermo Fisher Scientific entered into a strategic collaboration in May 2019 for accelerating various gene and cell therapy and microRNA therapy commercialization.
  • The Medicines Company was acquired by Novartis in November 2019 for about USD 9.7 billion. The objective behind this massive collaboration is to add potential miRNA and siRNA first-in-class inhibitor and continue building pipeline depth in such therapeutics.

MicroRNA Market – Growth Drivers

The mechanical development for working on the responsiveness and selectivity of miRNA identification is further adding to the development of the market for microRNA. The recently evolved techniques for miRNA recognition incorporate nanoparticle-based amplification, RCA-based strategies, DSN-based strategies, LAMP-based strategies, and without enzyme amplification, that may further add in favor of the market competition. In January 2020, scientists fostered a program-based isothermal amplification strategy for explicit and quantitative advanced estimation of miRNA. The upside of the framework is that pollution is diminished by the way that this framework is subject to the sign amplification process instead of coordinating replication of the designated grouping, as it completes the utilization of PCR-based methodologies.

Request a sample to get extensive insights into the MicroRNA Market

MicroRNA Market – Regional Insights

Geographically, the global microRNA market was dominated by North America on account of the presence of better research centers and highly efficient scientists specializing in the fields of oncology, genomics, proteomics, and others. For example, DiamiR got a U.S. Patent endorsement for miRNA-based techniques that are utilized for observing mind aging and discovery in May 2020. This patent covers the utilization of techniques for quantitative examination of miRNA present in discernible blood plasma and mind as biomarkers of cerebrum aging.

Micro-RNA Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes


Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.


Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved